Akcea and Ionis report positive topline phase 2 study results of AKCEA-ANGPTL3-LRx

Ads

You May Also Like

ZH Healthcare announces blueEHR collaboration with Sanford Health to enable global healthcare

MCLEAN, Va., Sept. 18, 2017 (GLOBE NEWSWIRE) -- ZH Healthcare announced that blueEHR, the company’s customizable eHealth ...

Sun Biopharma, Inc. Presents Poster at Pancreasfest in Pittsburgh, Pa.

Results of Phase 1 Safety Study of SBP-101 for Pancreatic Ductal AdenocarcinomaPancreasFest is an ...